GLP ‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels
Microcirculation · 2026
DOI: 10.1111/micc.70070 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microcirculation, 2026. Verfasst von Mary E Schulz und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, USA. Hauptthemen laut MEDLINE: Endothelium, Lymphatic, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide-1 Receptor Agonists, Lymphatic Vessels. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Objectives
Recent clinical studies have suggested that glucagon‐like peptide‐1 receptor (GLP‐1R) agonists may be effective therapies to treat or reduce the risk of developing secondary lymphedema. In this study, we aimed to (1) determine if GLP‐1Rs are present in the lymphatic vasculature and characterize their expression, and (2) assess the effects of GLP‐1R agonism on the contractile function of collecting lymphatic vessels.
Methods
We assessed the expression of GLP‐1Rs in and around the lymphatic vasculature by single‐cell RNA sequencing and fluorescence confocal microscopy, and evaluated the direct effects of GLP‐1R agonist, semaglutide, on modulating lymphatic contractility using pressure myography.
Results
Expression of Glp1r (encoding GLP‐1Rs) was detected exclusively in lymphatic endothelial cells. Pharmacological activation of GLP‐1Rs led to robust vasodilation and an increase in the pumping capacity of isolated collecting lymphatics from WT, diet‐induced obese, and hypercholesterolemic ApoE KO mice. The GLP‐1R‐mediated response was in part facilitated by nitric oxide and its potential interaction with NaV channels; however, additional signaling remains to be elucidated.
Conclusions
Our results revealed a direct, beneficial effect of GLP‐1R agonism on lymphatic pumping capacity mediated by robust vasodilation, allowing lymphatics to accommodate and displace larger fluid volumes while maintaining strong and highly efficient contractions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
- The Institute for Advanced Reconstruction, Glen Rock, New Jersey, USA.
- The Institute for Lymphatic Surgery & Innovation, Glen Rock, New Jersey, USA.
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Schulz, M. E., Akerstrom, V. L., Dayan, J. H., & Castorena-Gonzalez, J. A. (2026). GLP ‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels. Microcirculation. https://doi.org/10.1111/micc.70070
Vancouver
Schulz ME, Akerstrom VL, Dayan JH, Castorena-Gonzalez JA. GLP ‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels. Microcirculation. 2026. doi:10.1111/micc.70070
BibTeX
@article{Schulz2026,
author = {Schulz, Mary E and Akerstrom, Victoria L and Dayan, Joseph H and Castorena-Gonzalez, Jorge A},
title = {GLP ‐1 Receptors Are Enriched in the Lymphatic Endothelium and Their Pharmacological Activation With Semaglutide Improves the Pumping Capacity of Lymphatic Vessels},
journal = {Microcirculation},
year = {2026},
doi = {10.1111/micc.70070}
}
EUVIMED